TCL Archive Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall September 15, 1978
TCL Archive DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way October 3, 1975
TCL Archive NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants February 14, 1992
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
